Cargando…
House dust mite‐specific immunotherapy with two licensed vaccines: Outcome under clinical routine conditions
INTRODUCTION: House dust mite (HDM) allergens are major causes for the development of allergic diseases. A disease modifying effect and clinical benefit of allergen immunotherapy (AIT) has been demonstrated in a number of clinical trials. Clinical trials, however, are carried out in selected populat...
Autores principales: | Mahler, Vera, Klein, Christian, Sager, Angelika, Zimmermann, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418138/ https://www.ncbi.nlm.nih.gov/pubmed/28474505 http://dx.doi.org/10.1002/iid3.141 |
Ejemplares similares
-
Immunotherapy of house dust mite allergy
por: Yang, Lin, et al.
Publicado: (2017) -
New approaches to immunotherapy in house dust mite allergy
por: Kim, In Sik
Publicado: (2022) -
Acute systemic reactions to sublingual immunotherapy for house dust mite
por: Janssens, Nicky S., et al.
Publicado: (2020) -
House Dust Mite Allergy Under Changing Environments
por: Acevedo, Nathalie, et al.
Publicado: (2019) -
Variation in allergen content in sublingual allergen immunotherapy with house dust mites
por: Moreno Benítez, F., et al.
Publicado: (2015)